By Daniel Dunkin Recombivax is the Trade Name for Merck & Co’s Hepatitis B vaccine. The Recombivax Hepatitis B Vaccine Ingredients include genetic sequence of the hepatitis B virus that codes for the surface antigen (HbSAg), cloned into GMO yeast, and the chemicals aluminum hydroxide and thimerosal. Injection of any foreign antibodies or proteins is […]
Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
Press Release by Inovio Pharmaceuticals BLUE BELL, Pa., Feb. 7, 2011 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the […]
Merck’s Gardasil Prevents HPV Infection, Genital Warts in Men
Note from SaneVax: Perhaps the most critical information in this article is Merck funded, designed and analyzed the data from this study. According to Merck’s report, Gardasil generated sales of $767.6 million in the first three quarters of 2010.
MERCK'S GARDASIL VACCINE NOT PROVEN SAFE FOR LITTLE GIRLS
“Informed consent can be effectively exercised only if the patient possesses enough information to enable an intelligent choice (AMA, 1999).”
UPDATE 1-U.S. FDA blocks Novartis's Menveo for infants
By Katie Reid ZURICH, Jan 31 (Reuters) – Novartis AG’s (NOVN.VX) vaccine against meningococcal disease, a cause of potentially deadly meningitis, failed to get U.S. backing for use in infants between two months and 12 months of age, the Swiss drugmaker said. The news comes as a setback for Novartis’s meningitis franchise as its Vaccines […]
- « Previous Page
- 1
- …
- 46
- 47
- 48
- 49
- 50
- …
- 57
- Next Page »
